American Biologics Cancer Program
In this video, Luz BravoChip White spends about 28 minutes speaking on "American Biologics Cancer Program" at the 29th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Luz Bravo
LUZ BRAVO, M.D. graduated from Universidad Autonoma de Baja California in 1983. As Medical Director of Hospital American Biologics, she brings over 15 years of experience utilizing integrative medicine into day to day practice. She has managed patients with every form of degenerative disease and is well versed in the use of the advanced Bradford Microscope System. This includes expertise in the Bradford HLB (Heitan-Legard-Bradford) and HRBM (high resolution blood morphology).
Aside from overseeing Professor Bradford’s 11 physicians and 15 nurses, she also oversees the advanced technology at Hospital American Biologic’s hospital annex, Hospital Meridien. Here, patients in need of advanced Perfusion Hyperthermia avail themselves of the latest in Hyperthermia Technology. The surgical suites and recovery room compete favorably with any hospital.
In addition, Dr. Bravo is Medical Director for Hospital Meridien, where those patients requiring Gerson Therapy are treated by the only physicians in the world with extensive Gerson Therapy experience. In collaboration with Professor Bradford, Dr. Bravo has been responsible for reintroducing Calves Liver Juice into Gerson Protocols. She and Dr. Alicia Melendez have been the Chief Physicians at Hospital Meridien for the past 6 years.
Finally, Dr. Bravo is responsible for overseeing quality control for Professor Bradford’s advanced Oxidative Therapies, the Anti-Aging Protocols, the Anti-Microbial Protocols, Bioelectrical Therapies as well as the Detoxification Modalities.
Transcription
Good evening to all of you.
My name is Muddy Evitable, and I'm the medical director for American Biologics and Hospital mooradian.
We will talk tonight about Bradford through a piece.
That are done at American Biologics Hospital down in Tijuana, Mexico.
Chip White here.
We'll talk to you about the different assessments and protocols that are used in the clinic. And myself. I'll talk about the microscopy test.
Thanks very much. I wanted to digress for just one moment and say that this, I guess next year will be the 30th year for the Cancer Control Society.
Norm Freds, Lorraine Rosenthal, Frank Cousineau and all the rest of the staff do such an incredible job of making this convention happen and keeping things running smoothly.
And it makes it a joy for us presenters, particularly those of us, to do a lot of different shows, too, to work with these folks. And I just wanted to take a moment to thank these folks that may not get thanked all that often. So if you have a. Anyway, very, very briefly, I just wanted to clarify. Sometimes it's a little bit confusing for people. What the relationship is. Dr. Bravo is the medical director, both of Hospital mooradian and of American biologics. And their sister facilities that basically share resources. Some of the procedures that American biologic patients receive are done at Meridien because Meridien has intensive care facilities and surgical facilities that the aybe physical plant does not have. So they work together very closely and they're similar. You know, there are similar staffing and a lot of the underlying processes, all of the protocols are very different. A lot of the underlying philosophy of how we're treating the disease. There are some some similarities there. The American biologics approach to illness is basically something that Dr. Robert Radford developed more than 30 years ago and has been refining ever since an American biologics. In addition to its facility in Tijuana, has other facilities in Taiwan, in China, in Europe, in a number of other places. So it's really a worldwide research effort and a worldwide treatment effort. And as such, he has the opportunity to work closely with physicians in a number of different locations where the different with different patient populations that we typically might not necessarily see at the two wanted facility. So those resources of, you know, being able to see what's happening and what's working in China, in Taiwan gives us the opportunity for protocol development that some of the other facilities in Tijuana may not have the access to or the opportunity to use. I think that one of the things that really